The stock market enters the week with records behind it and a test ahead: corporate results season is arriving just as the busiest IPO pipeline in a decade — six companies across tech, dairy, pharma and energy — prepares to draw fresh capital toward new listings.
Earnings will decide whether the rally's arithmetic holds. The index's climb has been driven by rate-cut expectations and foreign buying; valuations are no longer at the deep discounts of two years ago, so banks, cement and energy results need to confirm the growth the prices assume.
For retail investors, the discipline notes remain unchanged: index records are a terrible reason to buy and an equally bad reason to panic; new IPOs deserve prospectus reading rather than listing-day chasing; and rupee-cost averaging into broad exposure has beaten timing in every recent cycle. This is market commentary, not investment advice — invest what your situation allows.